The Level Study

• Study Objective:
• To evaluate the efficacy of a new treatment aimed at enhancing the conversion of ammonia to urea in patients with urea cycle disorders (UCD).
  
  
• Understanding UCD:
• UCDs are a collection of genetic anomalies that disrupt the normal conversion of ammonia into urea, resulting in elevated ammonia levels in the body, which can cause significant health complications.
  
  
• Importance of Prevention:
• Managing ammonia levels is crucial for individuals with UCD. Current strategies include dietary protein restriction and ammonia-lowering agents.
• However, the development of additional treatments is essential for improved health outcomes.
  
  
• Clinical Trial Details:
• An independent ethics committee has approved this clinical trial.
• Participants will be reimbursed for their time
  

Call us on 1800 243 733 to discuss your eligibility today!